Theodore S. Hong
Showed how radiation, including proton therapy, can be used in liver and pancreatic cancers previously considered unsuitable.
Radiation oncologist leading proton and SBRT studies in hepatobiliary and pancreatic cancers, and neoadjuvant chemoradiation combinations including losartan-based stromal modulation.
| Title | Journal | Year |
|---|---|---|
| Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Journal of Clinical Oncology | 2016 |
Pages like this
not linked directly; found by shared links- InstitutionHokkaido University Hospital
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma.
- TechnologyBiliary stenting and drainage
Shares Biliary tract cancer (cholangiocarcinoma), Pancreatic ductal adenocarcinoma.
- PersonTheodore S. Lawrence
Shares SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma.
- IdeaLosartan to loosen the stroma of pancreatic cancer before chemotherapy: a phase 3
Shares Massachusetts General Hospital Cancer Center, Pancreatic ductal adenocarcinoma.
- PersonAlbert C. Koong
Shares SBRT / SABR (stereotactic radiotherapy), Pancreatic ductal adenocarcinoma.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy).
- InstitutionUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy).
- InstitutionNational Cancer Centre Singapore
Shares Proton therapy, Biliary tract cancer (cholangiocarcinoma), Hepatocellular carcinoma.